Rankings
▼
Calendar
ZBIO Q1 2024 Earnings — Zenas BioPharma, Inc. Revenue & Financial Results | Market Cap Arena
ZBIO
Zenas BioPharma, Inc.
$1B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$23M
Operating Income
-$28M
Net Income
-$28M
EPS (Diluted)
$-0.73
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$947,000
Balance Sheet
Total Assets
$49M
Total Liabilities
$302M
Stockholders' Equity
-$252M
Cash & Equivalents
$37M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$23M
$0
—
Operating Income
-$28M
-$19M
-44.5%
Net Income
-$28M
-$19M
-45.6%
← FY 2024
All Quarters
Q2 2024 →